✦ LIBER ✦

Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis

✍ Scribed by R.G. Masterton; C.J. Burley

Book ID: 119563333
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 102 KB
Volume: 18
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(01)00435-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind study compari

A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis

✍ S Sethi; C Fogarty; A Fulambarker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Randomized double-blind study comparing

Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis

✍ John UpChurch; Michael Rosemore; Robert Tosiello; Steven Kowalsky; Roger Echols 📂 Article 📅 2006 🏛 SAGE Publications 🌐 English ⚖ 94 KB

Phase III, randomized, double-blind stud

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis

✍ Jay L Adler; William Jannetti; David Schneider; Jie Zhang; Robert Palmer; Gerard 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 813 KB

Double-blind comparative study of ofloxa

Double-blind comparative study of ofloxacin (hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease

✍ N. P. Boye; P. Gaustad 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 454 KB

Pharmacokinetic and Pharmacodynamic Aspe

Pharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

✍ Dr Federico Pea, Federica Pavan, Emilio Lugatti, Flavio Dolcet, Giovanni Talmass 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 134 KB

Oral gemifloxacin once daily for 5 days

Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis

✍ R. WILSON; C. LANGAN; P. BALL; K. BATEMAN; R. PYPSTRA 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB